-
1
-
-
80051596116
-
GLOBOCAN 2008
-
Lyon, France: International Agency for Research on Cancer; 2010
-
Ferlay J SH, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010.
-
(2010)
Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]
-
-
Ferlay, J.S.H.1
Bray, F.2
Forman, D.3
Mathers, C.4
Parkin, D.M.5
-
2
-
-
79551584513
-
Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases
-
Ali S, Buluwela L, Coombes RC, (2011) Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other Diseases. Annual Review of Medicine 62: 217-232.
-
(2011)
Annual Review of Medicine
, vol.62
, pp. 217-232
-
-
Ali, S.1
Buluwela, L.2
Coombes, R.C.3
-
3
-
-
0035976638
-
Nuclear Receptors and Lipid Physiology: Opening the X-Files
-
Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ, (2001) Nuclear Receptors and Lipid Physiology: Opening the X-Files. Science 294: 1866-1870.
-
(2001)
Science
, vol.294
, pp. 1866-1870
-
-
Chawla, A.1
Repa, J.J.2
Evans, R.M.3
Mangelsdorf, D.J.4
-
4
-
-
0035995602
-
Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
-
Anderson E, (2002) Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4: 197-201.
-
(2002)
Breast Cancer Res
, vol.4
, pp. 197-201
-
-
Anderson, E.1
-
5
-
-
67349223542
-
Estrogen receptor beta in breast cancer-Diagnostic and therapeutic implications
-
Hartman J, Ström A, Gustafsson J-Å, (2009) Estrogen receptor beta in breast cancer-Diagnostic and therapeutic implications. Steroids 74: 635-641.
-
(2009)
Steroids
, vol.74
, pp. 635-641
-
-
Hartman, J.1
Ström, A.2
Gustafsson, J.-Å.3
-
6
-
-
0033637703
-
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
-
Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M, (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103: 843-852.
-
(2000)
Cell
, vol.103
, pp. 843-852
-
-
Shang, Y.1
Hu, X.2
DiRenzo, J.3
Lazar, M.A.4
Brown, M.5
-
7
-
-
0023034983
-
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells
-
Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU, (1986) An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46: 1053-1061.
-
(1986)
Cell
, vol.46
, pp. 1053-1061
-
-
Klein-Hitpass, L.1
Schorpp, M.2
Wagner, U.3
Ryffel, G.U.4
-
8
-
-
0034088842
-
Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements
-
Saville B, Wormke M, Wang F, Nguyen T, Enmark E, et al. (2000) Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275: 5379-5387.
-
(2000)
J Biol Chem
, vol.275
, pp. 5379-5387
-
-
Saville, B.1
Wormke, M.2
Wang, F.3
Nguyen, T.4
Enmark, E.5
-
9
-
-
0034735861
-
Estrogen receptor pathways to AP-1
-
Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, et al. (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74: 311-317.
-
(2000)
J Steroid Biochem Mol Biol
, vol.74
, pp. 311-317
-
-
Kushner, P.J.1
Agard, D.A.2
Greene, G.L.3
Scanlan, T.S.4
Shiau, A.K.5
-
10
-
-
38749099022
-
Differential Regulation of Native Estrogen Receptor-Regulatory Elements by Estradiol, Tamoxifen, and Raloxifene
-
Levy N, Tatomer D, Herber CB, Zhao X, Tang H, et al. (2008) Differential Regulation of Native Estrogen Receptor-Regulatory Elements by Estradiol, Tamoxifen, and Raloxifene. Molecular Endocrinology 22: 287-303.
-
(2008)
Molecular Endocrinology
, vol.22
, pp. 287-303
-
-
Levy, N.1
Tatomer, D.2
Herber, C.B.3
Zhao, X.4
Tang, H.5
-
11
-
-
0030941737
-
Coronary heart disease mortality and adjuvant tamoxifen therapy
-
Costantino JP, Kuller LH, Ives DG, Fisher B, Dignam J, (1997) Coronary heart disease mortality and adjuvant tamoxifen therapy. J Natl Cancer Inst 89: 776-782.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 776-782
-
-
Costantino, J.P.1
Kuller, L.H.2
Ives, D.G.3
Fisher, B.4
Dignam, J.5
-
12
-
-
27944492407
-
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
-
Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652-1662.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1652-1662
-
-
Fisher, B.1
Costantino, J.P.2
Wickerham, D.L.3
Cecchini, R.S.4
Cronin, W.M.5
-
13
-
-
0028212970
-
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study
-
Kristensen B, Ejlertsen B, Dalgaard P, Larsen L, Holmegaard SN, et al. (1994) Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. J Clin Oncol 12: 992-997.
-
(1994)
J Clin Oncol
, vol.12
, pp. 992-997
-
-
Kristensen, B.1
Ejlertsen, B.2
Dalgaard, P.3
Larsen, L.4
Holmegaard, S.N.5
-
14
-
-
0027325734
-
Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group
-
Rutqvist LE, Mattsson A, (1993) Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. J Natl Cancer Inst 85: 1398-1406.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1398-1406
-
-
Rutqvist, L.E.1
Mattsson, A.2
-
15
-
-
0026585852
-
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
-
Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, et al. (1992) Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852-856.
-
(1992)
N Engl J Med
, vol.326
, pp. 852-856
-
-
Love, R.R.1
Mazess, R.B.2
Barden, H.S.3
Epstein, S.4
Newcomb, P.A.5
-
16
-
-
0028208456
-
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
-
Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, et al. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86: 527-537.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 527-537
-
-
Fisher, B.1
Costantino, J.P.2
Redmond, C.K.3
Fisher, E.R.4
Wickerham, D.L.5
-
17
-
-
0037192501
-
Molecular determinants for the tissue specificity of SERMs
-
Shang Y, Brown M, (2002) Molecular determinants for the tissue specificity of SERMs. Science 295: 2465-2468.
-
(2002)
Science
, vol.295
, pp. 2465-2468
-
-
Shang, Y.1
Brown, M.2
-
18
-
-
33644641663
-
Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity
-
Soto AM, Maffini MV, Schaeberle CM, Sonnenschein C, (2006) Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Practice & Research Clinical Endocrinology & Metabolism 20: 15-33.
-
(2006)
Best Practice & Research Clinical Endocrinology & Metabolism
, vol.20
, pp. 15-33
-
-
Soto, A.M.1
Maffini, M.V.2
Schaeberle, C.M.3
Sonnenschein, C.4
-
19
-
-
0036744821
-
Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function
-
Xu J, O'Malley BW, (2002) Molecular mechanisms and cellular biology of the steroid receptor coactivator (SRC) family in steroid receptor function. Rev Endocr Metab Disord 3: 185-192.
-
(2002)
Rev Endocr Metab Disord
, vol.3
, pp. 185-192
-
-
Xu, J.1
O'Malley, B.W.2
-
20
-
-
0030797902
-
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
-
Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, et al. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968.
-
(1997)
Science
, vol.277
, pp. 965-968
-
-
Anzick, S.L.1
Kononen, J.2
Walker, R.L.3
Azorsa, D.O.4
Tanner, M.M.5
-
21
-
-
4544314561
-
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene
-
Torres-Arzayus MI, Font de Mora J, Yuan J, Vazquez F, Bronson R, et al. (2004) High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6: 263-274.
-
(2004)
Cancer Cell
, vol.6
, pp. 263-274
-
-
Torres-Arzayus, M.I.1
Font de Mora, J.2
Yuan, J.3
Vazquez, F.4
Bronson, R.5
-
22
-
-
0035968330
-
Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells
-
List H-J, Lauritsen KJ, Reiter R, Powers C, Wellstein A, et al. (2001) Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells. Journal of Biological Chemistry 276: 23763-23768.
-
(2001)
Journal of Biological Chemistry
, vol.276
, pp. 23763-23768
-
-
List, H.-J.1
Lauritsen, K.J.2
Reiter, R.3
Powers, C.4
Wellstein, A.5
-
23
-
-
64049119546
-
Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity
-
Karmakar S, Foster EA, Smith CL, (2009) Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity. Endocrinology 150: 1588-1596.
-
(2009)
Endocrinology
, vol.150
, pp. 1588-1596
-
-
Karmakar, S.1
Foster, E.A.2
Smith, C.L.3
-
24
-
-
0035356577
-
Split Luciferase as an Optical Probe for Detecting Proteinâ?'Protein Interactions in Mammalian Cells Based on Protein Splicing
-
Ozawa T, Kaihara A, Sato M, Tachihara K, Umezawa Y, (2001) Split Luciferase as an Optical Probe for Detecting Proteinâ?'Protein Interactions in Mammalian Cells Based on Protein Splicing. Analytical Chemistry 73: 2516-2521.
-
(2001)
Analytical Chemistry
, vol.73
, pp. 2516-2521
-
-
Ozawa, T.1
Kaihara, A.2
Sato, M.3
Tachihara, K.4
Umezawa, Y.5
-
26
-
-
33947380192
-
Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions
-
Paulmurugan R, Gambhir SS, (2007) Combinatorial library screening for developing an improved split-firefly luciferase fragment-assisted complementation system for studying protein-protein interactions. Anal Chem 79: 2346-2353.
-
(2007)
Anal Chem
, vol.79
, pp. 2346-2353
-
-
Paulmurugan, R.1
Gambhir, S.S.2
-
27
-
-
0024440781
-
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
-
Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, et al. (1989) The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. Embo J 8: 1981-1986.
-
(1989)
Embo J
, vol.8
, pp. 1981-1986
-
-
Tora, L.1
Mullick, A.2
Metzger, D.3
Ponglikitmongkol, M.4
Park, I.5
-
28
-
-
77952812169
-
Guidelines for the welfare and use of animals in cancer research
-
Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, et al. (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.
-
(2010)
Br J Cancer
, vol.102
, pp. 1555-1577
-
-
Workman, P.1
Aboagye, E.O.2
Balkwill, F.3
Balmain, A.4
Bruder, G.5
-
29
-
-
0026064491
-
Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient
-
Robinson SP, Langan-Fahey SM, Johnson DA, Jordan VC, (1991) Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metabolism and Disposition 19: 36-43.
-
(1991)
Drug Metabolism and Disposition
, vol.19
, pp. 36-43
-
-
Robinson, S.P.1
Langan-Fahey, S.M.2
Johnson, D.A.3
Jordan, V.C.4
-
31
-
-
0023501880
-
Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration
-
DeGregorio MW, Wilbur BJ, Coronado E, Osborne CK, (1987) Serum tamoxifen concentrations in the athymic nude mouse after three methods of administration. Cancer Chemotherapy and Pharmacology 20: 316-318.
-
(1987)
Cancer Chemotherapy and Pharmacology
, vol.20
, pp. 316-318
-
-
DeGregorio, M.W.1
Wilbur, B.J.2
Coronado, E.3
Osborne, C.K.4
-
32
-
-
0037320982
-
Tamoxifen administration and metabolism in nude mice and nude rats
-
Kisanga ER, Gjerde J, Schjott J, Mellgren G, Lien EA, (2003) Tamoxifen administration and metabolism in nude mice and nude rats. J Steroid Biochem Mol Biol 84: 361-367.
-
(2003)
J Steroid Biochem Mol Biol
, vol.84
, pp. 361-367
-
-
Kisanga, E.R.1
Gjerde, J.2
Schjott, J.3
Mellgren, G.4
Lien, E.A.5
-
33
-
-
0035984722
-
Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions
-
Galarneau A, Primeau M, Trudeau LE, Michnick SW, (2002) Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nat Biotechnol 20: 619-622.
-
(2002)
Nat Biotechnol
, vol.20
, pp. 619-622
-
-
Galarneau, A.1
Primeau, M.2
Trudeau, L.E.3
Michnick, S.W.4
-
34
-
-
0037397074
-
Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation
-
Paulmurugan R, Gambhir SS, (2003) Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation. Anal Chem 75: 1584-1589.
-
(2003)
Anal Chem
, vol.75
, pp. 1584-1589
-
-
Paulmurugan, R.1
Gambhir, S.S.2
-
35
-
-
0031059270
-
The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
-
Anstead GM, Carlson KE, Katzenellenbogen JA, (1997) The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62: 268-303.
-
(1997)
Steroids
, vol.62
, pp. 268-303
-
-
Anstead, G.M.1
Carlson, K.E.2
Katzenellenbogen, J.A.3
-
36
-
-
0034991013
-
Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes
-
Bramlett KS, Wu Y, Burris TP, (2001) Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol Endocrinol 15: 909-922.
-
(2001)
Mol Endocrinol
, vol.15
, pp. 909-922
-
-
Bramlett, K.S.1
Wu, Y.2
Burris, T.P.3
-
37
-
-
0033744048
-
Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members
-
Kraichely DM, Sun J, Katzenellenbogen JA, Katzenellenbogen BS, (2000) Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 141: 3534-3545.
-
(2000)
Endocrinology
, vol.141
, pp. 3534-3545
-
-
Kraichely, D.M.1
Sun, J.2
Katzenellenbogen, J.A.3
Katzenellenbogen, B.S.4
-
38
-
-
0026395885
-
A potent specific pure antiestrogen with clinical potential
-
Wakeling AE, Dukes M, Bowler J, (1991) A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873.
-
(1991)
Cancer Res
, vol.51
, pp. 3867-3873
-
-
Wakeling, A.E.1
Dukes, M.2
Bowler, J.3
-
39
-
-
0031039888
-
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
-
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870.
-
(1997)
Endocrinology
, vol.138
, pp. 863-870
-
-
Kuiper, G.G.1
Carlsson, B.2
Grandien, K.3
Enmark, E.4
Haggblad, J.5
-
40
-
-
0026600841
-
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
-
Danielian PS, White R, Lees JA, Parker MG, (1992) Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. Embo J 11: 1025-1033.
-
(1992)
Embo J
, vol.11
, pp. 1025-1033
-
-
Danielian, P.S.1
White, R.2
Lees, J.A.3
Parker, M.G.4
-
41
-
-
0030445855
-
Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein
-
Weis KE, Ekena K, Thomas JA, Lazennec G, Katzenellenbogen BS, (1996) Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol 10: 1388-1398.
-
(1996)
Mol Endocrinol
, vol.10
, pp. 1388-1398
-
-
Weis, K.E.1
Ekena, K.2
Thomas, J.A.3
Lazennec, G.4
Katzenellenbogen, B.S.5
-
42
-
-
0342547258
-
Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine
-
White R, Sjoberg M, Kalkhoven E, Parker MG, (1997) Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. Embo J 16: 1427-1435.
-
(1997)
Embo J
, vol.16
, pp. 1427-1435
-
-
White, R.1
Sjoberg, M.2
Kalkhoven, E.3
Parker, M.G.4
-
43
-
-
0037340143
-
A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment
-
Liu J, Knappenberger KS, Kack H, Andersson G, Nilsson E, et al. (2003) A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment. Mol Endocrinol 17: 346-355.
-
(2003)
Mol Endocrinol
, vol.17
, pp. 346-355
-
-
Liu, J.1
Knappenberger, K.S.2
Kack, H.3
Andersson, G.4
Nilsson, E.5
-
44
-
-
0032230368
-
Nuclear Receptors Have Distinct Affinities for Coactivators: Characterization by Fluorescence Resonance Energy Transfer
-
Zhou G, Cummings R, Li Y, Mitra S, Wilkinson HA, et al. (1998) Nuclear Receptors Have Distinct Affinities for Coactivators: Characterization by Fluorescence Resonance Energy Transfer. Mol Endocrinol 12: 1594-1604.
-
(1998)
Mol Endocrinol
, vol.12
, pp. 1594-1604
-
-
Zhou, G.1
Cummings, R.2
Li, Y.3
Mitra, S.4
Wilkinson, H.A.5
-
45
-
-
0037385141
-
Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells
-
Bai Y, Giguere V, (2003) Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. Mol Endocrinol 17: 589-599.
-
(2003)
Mol Endocrinol
, vol.17
, pp. 589-599
-
-
Bai, Y.1
Giguere, V.2
-
46
-
-
0034636104
-
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
-
Llopis J, Westin S, Ricote M, Wang Z, Cho CY, et al. (2000) Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. Proc Natl Acad Sci U S A 97: 4363-4368.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 4363-4368
-
-
Llopis, J.1
Westin, S.2
Ricote, M.3
Wang, Z.4
Cho, C.Y.5
-
47
-
-
68049131211
-
The construction of a glucose-sensing luciferase
-
Taneoka A, Sakaguchi-Mikami A, Yamazaki T, Tsugawa W, Sode K, (2009) The construction of a glucose-sensing luciferase. Biosens Bioelectron 25: 76-81.
-
(2009)
Biosens Bioelectron
, vol.25
, pp. 76-81
-
-
Taneoka, A.1
Sakaguchi-Mikami, A.2
Yamazaki, T.3
Tsugawa, W.4
Sode, K.5
-
48
-
-
49049108182
-
Imaging CXCR4 Signaling with Firefly Luciferase Complementation
-
Luker KE, Gupta M, Luker GD, (2008) Imaging CXCR4 Signaling with Firefly Luciferase Complementation. Anal Chem 80: 5565-5573.
-
(2008)
Anal Chem
, vol.80
, pp. 5565-5573
-
-
Luker, K.E.1
Gupta, M.2
Luker, G.D.3
-
49
-
-
34548656928
-
Nongenomic Activity of Ligands in the Association of Androgen Receptor with Src
-
Kim SB, Kanno A, Ozawa T, Tao H, Umezawa Y, (2007) Nongenomic Activity of Ligands in the Association of Androgen Receptor with Src. ACS Chem Biol 2: 484-492.
-
(2007)
ACS Chem Biol
, vol.2
, pp. 484-492
-
-
Kim, S.B.1
Kanno, A.2
Ozawa, T.3
Tao, H.4
Umezawa, Y.5
-
50
-
-
65549138069
-
Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor
-
Yang KS, Ilagan MX, Piwnica-Worms D, Pike LJ, (2009) Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor. J Biol Chem 284: 7474-7482.
-
(2009)
J Biol Chem
, vol.284
, pp. 7474-7482
-
-
Yang, K.S.1
Ilagan, M.X.2
Piwnica-Worms, D.3
Pike, L.J.4
-
51
-
-
0033751348
-
Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells
-
Tikkanen MK, Carter DJ, Harris AM, Le HM, Azorsa DO, et al. (2000) Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 97: 12536-12540.
-
(2000)
Proceedings of the National Academy of Sciences of the United States of America
, vol.97
, pp. 12536-12540
-
-
Tikkanen, M.K.1
Carter, D.J.2
Harris, A.M.3
Le, H.M.4
Azorsa, D.O.5
-
52
-
-
34447331719
-
Bioluminescent Indicator for Determining Protein-Protein Interactions Using Intramolecular Complementation of Split Click Beetle Luciferase
-
Kim SB, Otani Y, Umezawa Y, Tao H, (2007) Bioluminescent Indicator for Determining Protein-Protein Interactions Using Intramolecular Complementation of Split Click Beetle Luciferase. Anal Chem 79: 4820-4826.
-
(2007)
Anal Chem
, vol.79
, pp. 4820-4826
-
-
Kim, S.B.1
Otani, Y.2
Umezawa, Y.3
Tao, H.4
-
53
-
-
79956327055
-
The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy
-
Della Torre S, Biserni A, Rando G, Monteleone G, Ciana P, et al. (2011) The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy. Endocrinology 152: 2256-2265.
-
(2011)
Endocrinology
, vol.152
, pp. 2256-2265
-
-
Della Torre, S.1
Biserni, A.2
Rando, G.3
Monteleone, G.4
Ciana, P.5
-
54
-
-
77950385395
-
An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals
-
Rando G, Horner D, Biserni A, Ramachandran B, Caruso D, et al. (2010) An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals. Mol Endocrinol 24: 735-744.
-
(2010)
Mol Endocrinol
, vol.24
, pp. 735-744
-
-
Rando, G.1
Horner, D.2
Biserni, A.3
Ramachandran, B.4
Caruso, D.5
-
55
-
-
44649160076
-
Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction
-
Gunther JR, Moore TW, Collins ML, Katzenellenbogen JA, (2008) Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction. ACS Chem Biol 3: 282-286.
-
(2008)
ACS Chem Biol
, vol.3
, pp. 282-286
-
-
Gunther, J.R.1
Moore, T.W.2
Collins, M.L.3
Katzenellenbogen, J.A.4
-
56
-
-
1642581072
-
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding
-
Rodriguez AL, Tamrazi A, Collins ML, Katzenellenbogen JA, (2004) Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. J Med Chem 47: 600-611.
-
(2004)
J Med Chem
, vol.47
, pp. 600-611
-
-
Rodriguez, A.L.1
Tamrazi, A.2
Collins, M.L.3
Katzenellenbogen, J.A.4
-
57
-
-
27744593102
-
Potent inhibitors of LXXLL-based protein-protein interactions
-
Galande AK, Bramlett KS, Trent JO, Burris TP, Wittliff JL, et al. (2005) Potent inhibitors of LXXLL-based protein-protein interactions. Chembiochem 6: 1991-1998.
-
(2005)
Chembiochem
, vol.6
, pp. 1991-1998
-
-
Galande, A.K.1
Bramlett, K.S.2
Trent, J.O.3
Burris, T.P.4
Wittliff, J.L.5
-
58
-
-
0041878673
-
What pharmacologists can learn from recent advances in estrogen signalling
-
Gustafsson JA, (2003) What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci 24: 479-485.
-
(2003)
Trends Pharmacol Sci
, vol.24
, pp. 479-485
-
-
Gustafsson, J.A.1
|